Pemvidutide vs Oxyntomodulin

Head-to-head comparison of Pemvidutide (Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) and Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyPemvidutideOxyntomodulin
CategoryWeight ManagementWeight Management
Full NamePemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonistEndogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Molecular WeightN/A~4,200 Da
Half-LifeApproximately 1 week12-15 minutes
Amino AcidsN/A37
Typical DoseTrial-dependent; once-weekly SC titrationResearch doses vary; commonly 100-300 mcg in small human studies
RouteSubcutaneousSubcutaneous/IV
Purity≥98%≥98%
Studies Count1880
Research StatusClinicalClinical

Pemvidutide Benefits

  • appetite suppression
  • body-weight reduction
  • improved liver-fat markers
  • better glycemic control

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

Pemvidutide Dosing

once-weekly subcutaneous injection|gradual dose escalation|maintenance at tolerated trial dose

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

Pemvidutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Research Overview

Pemvidutide

Clinical studies have reported dose-dependent weight loss and favorable effects on liver fat and transaminases. It remains investigational and is not approved for obesity treatment.

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Pemvidutide stacks with:

metformintopiramate

Oxyntomodulin stacks with:

calorie-deficitresistance-training
glp1glucagondual-agonistobesitymashGLP-1glucagon-coagonistendogenous-peptideappetite-regulation